Development gone awry: congenital heart disease

PJ Gruber, JA Epstein - Circulation research, 2004 - Am Heart Assoc
PJ Gruber, JA Epstein
Circulation research, 2004Am Heart Assoc
Significant advances in the understanding of the molecular and genetic basis of congenital
heart disease have emerged from gene inactivation studies in mice and from human genetic
investigations. However, the ability to utilize information gleaned from animal models to
inform clinical care of patients depends on an accurate anatomic analysis and presentation
in terms that are meaningful to the clinical pediatric cardiologist. Likewise, the enormous
depth and breadth of accumulated clinical experience can inform the developmental …
Significant advances in the understanding of the molecular and genetic basis of congenital heart disease have emerged from gene inactivation studies in mice and from human genetic investigations. However, the ability to utilize information gleaned from animal models to inform clinical care of patients depends on an accurate anatomic analysis and presentation in terms that are meaningful to the clinical pediatric cardiologist. Likewise, the enormous depth and breadth of accumulated clinical experience can inform the developmental biologist and can highlight the importance and interrelationships of particular phenotypes. The explosion of potentially informative genetic tools demands that basic scientists and clinicians concerned with congenital cardiac disease enhance the ongoing bidirectional dialogue. In some cases, categories of congenital disease familiar to clinicians are not recognized by developmental biologists, and mechanisms accepted by the biologist seem inconsistent with clinical experience. In this review, we summarize some of the more clinically significant forms of congenital heart disease, and we highlight relevant genetic and developmental pathways.
Am Heart Assoc